These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29463227)

  • 41. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
    Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
    Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
    Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
    Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program.
    Hofvind S; Sørum R; Thoresen S
    Acta Oncol; 2008; 47(2):225-31. PubMed ID: 17851868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
    Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
    J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.
    Beckmann KR; Lynch JW; Hiller JE; Farshid G; Houssami N; Duffy SW; Roder DM
    Int J Cancer; 2015 Mar; 136(6):1411-21. PubMed ID: 25098753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
    Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
    Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
    Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
    J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of sustained breast cancer incidence inflation in a national mammography screening programme.
    Morrell S; Gregory M; Sexton K; Wharton J; Sharma N; Taylor R
    J Med Screen; 2019 Mar; 26(1):26-34. PubMed ID: 29950138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
    van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
    Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No difference in the prevalence of benign breast changes between women from Ghana and Norway: an autopsy study.
    Stalsberg H; Adjei EK; Owusu-Afriyie O
    Breast Cancer Res Treat; 2015 May; 151(1):177-82. PubMed ID: 25893589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective study of the use and effects of screening mammography in women aged 70 and older.
    Vacek PM; Skelly JM
    J Am Geriatr Soc; 2015 Jan; 63(1):1-7. PubMed ID: 25537022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
    Séradour B; Allemand H; Weill A; Ricordeau P
    Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.